Nancy Cauwenberghs, PhD MSD

Nancy Cauwenberghs is a regulatory affairs professional with 18 years of continuous advancement and expertise in registration activities. Nancy possesses thorough knowledge of global CMC, clinical, non-clinical and labelling requirements for vaccines, as well as registration procedures.

Nancy was Head of Global CMC Regulatory Affairs at GSK Vaccines for many years, with primary focus on polysaccharide and conjugate vaccines. Afterwards, Nancy became Global Regulatory Lead for the meningococcal franchise at GSK Vaccines.

Nancy joined MSD Inc (Merck Sharp & Dohme Inc.) in 2016 as Sn Director, supporting and coordinating regulatory policy activities for MSD Inc for vaccines in Europe, and regulatory liaison & strategy work for vaccines.

Nancy holds a Bio-engineering Master's Degree from the Leuven University (Belgium) followed by a PhD, and a Master's in Intellectual Property.